AAAS

DEADLINE EXTENDED: there is still time to submit nominations for the second Multidisciplinary Working Group! This working group, “Disability Inclusion and Anti-Ableism in STEMM,” will be centered on advancing disability-inclusive policies and combating barriers like ableism, which have kept disabled scientists from entering and thriving in the STEMM enterprise. The MWGs feature diverse perspectives that work together to address timely and high-impact issues in STEMM while advancing the strategic vision of AAAS as a multidisciplinary, inclusive, mobilized scientific community. Nominations are now open until Friday, September 6, at 5:00 p.m. ET! Learn more about this working group, including how to apply or nominate someone to be a member here: https://bit.ly/46MLD9n

Programs like SciLine and the Mass Media Science & Engineering Fellowship help deliver accurate, accessible science news to Americans, helping to counteract misinformation and disinformation. Get the scoop in our latest Member Update: https://brnw.ch/21wM90X

While the GLP-1 agonist drug class may seem like it is taking the world by storm, medications to treat obesity existed for years before these latest iterations. But researchers like Richard DiMarchi wondered if their efficacy could be improved. Thanks to a “constructive combination” of two peptide hormones—gastric inhibitory polypeptide, and glucagon-like peptide—DiMarchi and associates noted a greater overall reduction of body weight occurring in rodents, compared to existing treatments. His team’s third step—adding in glucagon — made the drugs even more powerful. For his persistence and perseverance in advancing our understanding of GLP-1 agonist medications as an option for treating obesity, DiMarchi, alongside Lotte Bjerre Knudsen, received the AAAS Mani L. Bhaumik Breakthrough of the Year Award.

Together with Science Magazine and AAAS, we invite you to our webinar on September 18, which will focus on the women’s health gap and why sex matters in research. During the webinar, leading researchers and clinicians Liisa Galea, Aris Papageorghiou, and Henriette Svarre Nielsen will touch upon the following topics: 🤰Advancements in reproductive medicine, including the use of AI, and why this is not just a women’s issue 🧠 New research findings on sex differences and brain health 💊 How we can translate discoveries in women’s health into practical, marketable medical products and treatments 👩 The unique challenges that women face and the crucial role of sex-specific research in driving medical innovation 🎙 Erika Gebel Berg will moderate the webinar, which is part of Science Translational Medicine and BII’s collaboration centered around the 'BII & Science Translational Medicine Prize for Innovations in Women’s Health'. 🏆The prize aims to recognize researchers who have developed innovative advances with the translational potential to impact women’s health globally. The deadline for submissions is November 1, and researchers at any career stage who have completed their PhD, MD, or MD/PhD training are eligible to apply. You can register for the webinar here: https://bit.ly/3T2Mzkd Find more about the prize here: https://bit.ly/45AdCbQ Johanna Roostalu Cathrine Nygaard Christensen Angela Ibler Sanne Brun Jensen Trine Bartholdy Jens Nielsen Katrine Villarreal Villumsen Anders Østerby Mønsted Roger Goncalves Bill Moran Holden Thorp Sudip Parikh Michael Funk

⏰ Deadline reminder: AAAS is offering $50,000 awards to five institutions to pilot work on improving sexual orientation and gender identity (SOGI) data collection and use. Schools at any stage of collection are encouraged to apply. Deadline is Friday, August 30! Learn more: https://brnw.ch/21wM0rL

Publishers of open access journals have increasingly relied on substantial article-processing charges (APCs) to drive revenue. Critics of APCs fear that the model not only incentivizes quantity over quality, but amplifies long-standing inequities in global science. https://bit.ly/4fPS1AL

AAAS is thrilled to announce the topic of the second Multidisciplinary Working Group: “Disability Inclusion and Anti-Ableism in STEMM.” This working group is centered on advancing disability-inclusive policies and combating barriers like ableism, which have kept disabled scientists from entering and thriving in the STEMM enterprise. The MWGs feature diverse perspectives that work together to address timely and high-impact issues in STEMM while advancing the strategic vision of AAAS as a multidisciplinary, inclusive, mobilized scientific community. Nominations are open until Friday, August 23! Learn more about this working group, including how to apply or nominate someone to be a member here: https://bit.ly/46MLD9n

Thirty years ago, diabetes was declared as an epidemic in the United States. At the same time, a rise in obesity was sweeping the nation. While treatment development for diabetes skyrocketed, it took decades before obesity was even thought of, and treated as, a disease. Not everyone who is considered overweight or obese has associated health issues. But for millions of Americans, excess weight is linked to increased risks of numerous negative health effects including type 2 diabetes, hypertension, heart disease, fertility issues, and stroke. Researchers like Richard DiMarchi wondered why so few were tackling treating excess body weight as the root cause of these associated diseases. For his role in advancing our understanding of the GLP-1 agonist class of drugs as a treatment option for obesity, DiMarchi, alongside Lotte Bjerre Knudsen, received this year's AAAS Mani L. Bhaumik Breakthrough of the Year Award.

AAAS is thrilled to announce the topic of the second Multidisciplinary Working Group: “Disability Inclusion and Anti-Ableism in STEMM.” This working group is centered on advancing disability-inclusive policies and combating barriers like ableism, which have kept disabled scientists from entering and thriving in the STEMM enterprise. The MWGs feature diverse perspectives that work together to address timely and high-impact issues in STEMM while advancing the strategic vision of AAAS as a multidisciplinary, inclusive, mobilized scientific community. Nominations are open for one more week! Learn more about this working group, including how to apply or nominate someone to be a member here: https://bit.ly/46MLD9n

The Supreme Court's ruling to overturn the Chevron doctrine in June will place a bigger burden on judges and judicial employees to grapple with scientific evidence more directly. Theresa Harris, director of the AAAS Center for Scientific Responsibility and Justice, discussed the need for additional scientific support in the courts with the American Institute of Physics. Read the full story below ⤵️ https://brnw.ch/21wLLvn